Steven Simonson
Technik-/Wissenschafts-/F&E-Leiter bei WINDTREE THERAPEUTICS, INC.
Vermögen: 4 913 $ am 30.04.2024
Aktive Positionen von Steven Simonson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2014 | - |
| Corporate Officer/Principal | 20.05.2014 | 01.10.2014 |
Karriereverlauf von Steven Simonson
Ehemalige bekannte Positionen von Steven Simonson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGENNIX AG | Technik-/Wissenschafts-/F&E-Leiter | 18.04.2011 | 18.04.2011 |
| Corporate Officer/Principal | 02.07.2012 | 01.11.2012 | |
Agennix, Inc.
 Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Corporate Officer/Principal | - | 01.11.2012 |
| COVANCE INC. | Corporate Officer/Principal | - | - |
Ausbildung von Steven Simonson
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
| Duke University School of Medicine | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Agennix AG
 Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Steven Simonson
- Erfahrung
